Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics

Rationale: Fibroblast activation protein (FAP) targeted molecular imaging radiotracers have shown promising preclinical and clinical results in tumor diagnosis. However, rapid clearance and inadequate tumor retention of these molecules have hindered them for further clinical translation in cancer th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Xuejun, Xu, Pengfei, Shi, Mengqi, Liu, Jia, Zeng, Xinying, Zhang, Yiren, Shi, Changrong, Li, Jingchao, Guo, Zhide, Zhang, Xianzhong, Khong, Pek-Lan, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690933/
https://www.ncbi.nlm.nih.gov/pubmed/34987657
http://dx.doi.org/10.7150/thno.68182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690933/
https://www.ncbi.nlm.nih.gov/pubmed/34987657
http://dx.doi.org/10.7150/thno.68182

Ejemplares similares